| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman | CEO &President
3 companies
Leiden Jeffrey M is a Director at ODTX, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 120 sales. Those positions are worth an estimated $22.9M at current prices.
Our model assigns Leiden Jeffrey M a below-average insider score of 47/100, based on 17 past trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -11.7%.
Leiden Jeffrey M's largest disclosed position is in VRTX as Executive Chairman, worth about $16.9M. The recent filings there lean toward selling, a net 1,221,678 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sell10b5-1 | 10,958 | $349.98 | $3,835,061.76 | -22.7% | +0.4% | +15.5% | |
| Jul 25, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sale+OE | 132,079 | $281.38 | $37,164,480.57 | -98.2% | +9.5% | +26.2% | |
| Apr 13, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sell | 15,789 | $289.04 | $4,563,652.56 | -17.6% | -0.3% | +14.6% | |
| Jun 30, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sell | 30,458 | $285.82 | $8,705,419.43 | -93.1% | - | - | |
| May 12, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sale+OE | 94,370 | $283.47 | $26,751,440.10 | -73.0% | - | - | |
| May 7, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sale+OE | 94,369 | $269.78 | $25,459,013.12 | -69.8% | - | - | |
| May 5, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | Executive Chairman | Sale+OE | 94,372 | $269.94 | $25,475,036.61 | -66.9% | - | - | |
| Feb 25, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 10,550 | $233.46 | $2,463,045.63 | -10.2% | - | - | |
| Feb 18, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 11,685 | $243.52 | $2,845,518.24 | -9.5% | - | - | |
| Feb 11, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | CEO &President | Sell | 47,523 | $246.09 | $11,694,933.45 | -26.4% | - | - |